What Researchers Did
The authors wrote a review of how different gases, including ozone, hyperbaric oxygen, hydrogen, hydrogen sulfide and nitric oxide, are being used or studied for intervertebral disc degeneration.
What They Found
This narrative review of gas-based therapies for intervertebral disc degeneration concludes that current evidence indicates these therapies reduce pain and improve functional impairment, with ozone and hyperbaric oxygen described as already in clinical use. The abstract reports no sample sizes, pressures, session counts or statistics. It says hydrogen, hydrogen sulfide and nitric oxide are still at the preclinical stage. It describes the proposed mechanisms as scavenging reactive oxygen species, lowering inflammatory signals and supporting collagen production. It also says combining gases with stem cells, scaffolds or drug delivery systems shows synergistic potential.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This is a review, not a trial, and the abstract itself says that large multicenter randomized trials, standardized treatment parameters and better human-relevant disease models are still needed, and that several of the gases have only been tested preclinically.